Immune Response Associated Hepatotoxicity in Hemophilia Gene Therapy: Mechanisms, Management, and Challenges
{{output}}
Adeno-associated virus (AAV)-based gene therapy offers the potential for long-term functional cure in patients with hemophilia A and B. However, immune responses triggered by the vector capsid or transgene product, leading to hepatotoxicity, represent a major ... ...
